Robert Silverman

Dr. Silverman is the CEO and founder of Revere Pharmaceuticals. He served as General Counsel of Concert from 2007 to 2017, helping the company become public in 2014. Previously, Dr. Silverman was Associate General Counsel at Millennium Pharmaceuticals (now Takeda) and served in various legal roles at Vertex Pharmaceuticals and FMC Corporation. Dr. Silverman also lectures for the BIO Executive Training Programs.

Dr. Silverman started his career as a research chemist. He has over 20 US patents. Dr. Silverman received his BA degree from Lehigh University, his PhD from the U of New Mexico and did post-doctoral training in organic chemistry at Stanford University. He received his JD from Rutgers Law School.